
Sign up to save your podcasts
Or


Welcome to the 29th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today is a really fun episode! Mandy is joined by her co-host, founder and CEO of SOLABS, Philippe Gaudreau. And they're partnering together in this episode to discuss data migration as it relates to data integrity.
This topic has risen to the top in relevancy in the GMP world, so today, Mandy and Philippe will be highlighting some of the best practices and strategies to consider when implementing these key concepts into your organization!
Mandy explains the link between data migration and data integrity; defines the concept of data migration and the key phases that should be considered for inclusion when developing a migration strategy; and then, from a regulatory compliance perspective, highlights what must be considered with regards to data migration. Later on, Philippe explains what has changed in the data migration area over the years and suggests methods for creating efficient migration projects.
Key Takeaways:
[:28] About today's special episode!
[2:50] Jumping right into it, Philippe first asks Mandy to describe the importance of data migration in the Life Sciences space and to define the key phases of data migration.
[9:24] Mandy explains the link between data migration and data integrity.
[13:29] From a regulatory compliance perspective, what must be considered with regards to data migration?
[15:27] Philippe explains what has changed in the data migration area over the years from his perspective.
[18:55] Philippe suggests methods to create efficient migration projects.
[23:56] What are the international standards related to data migration?
[26:18] What are some qualification approaches and strategies to ensure data integrity?
[29:32] Mandy shares a personal experience with data migration processes.
[30:23] Mandy wraps up this week's episode and thanks Philippe for joining her today!
Mentioned in this Episode:
Automating Quality Ep. 6: "Data Integrity with Rich Greer"
Philippe Gaudreau on LinkedIn
Welcome to the 28th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode is all about regulatory convergence! In the world of globalization, it makes sense that we're finally starting to see extensive shifts in philosophy and regulations as they apply to the Life Sciences industry, which are setting new quality standards for drug and device manufacturers. It's a very exciting topic as there have been some incredibly notable changes in the last 5 years!
In this episode, Mandy will be highlighting some of the key pieces to consider when thinking about the concept of regulatory convergence and explains how it is driving extensive shifts in the Life Sciences space.
Key Takeaways:
[:28] About today's episode.
[1:00] Mandy explains what the term 'regulatory convergence' refers to.
[2:38] What is the Mutual Recognition Agreement (MRA) and how is it related to the concept of regulatory convergence?
[5:22] Mandy highlights some of the key benefits impacting public health that stem from regulatory harmonization.
[8:25] Mandy speaks about the two major international standard bodies that are playing a vital role in regulatory harmonization (or convergence) and highlights the technical areas that they are affecting.
[12:59] Mandy wraps up this week's episode and thanks listeners for tuning in!
Mentioned in this Episode:
World Health Organization (WHO)
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Welcome to the 27th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today on the podcast, Mandy is bringing you a topic that has yet to be discussed in-depth on the show, and that is Laboratory Investigation Reports (also known as LIRs) and critical elements to consider when designing or implementing enhancements to the quality management process. Ensuring that your LIR process is robust is critical to your business operation and will help set you up for success if scrutinized during an inspection. All-in-all, it is a key part of the QMS.
Joining Mandy today is Life Sciences veteran and Quality expert, Kathy Landes, to provide expert feedback on this topic! Kathryn has more than 20 years of experience and is an absolute wealth of knowledge in this space! As someone who has spent many years developing and managing QC laboratories as part of her career as a quality professional and knows the LIR process inside and out, Kathy sheds light on some of the key areas to consider, breaks down some of the processes to their fundamental parts, and highlights many important considerations related to LIR.
Key Takeaways:
[:30] About today's episode.
[1:22] Mandy welcomes Kathryn Landes to the podcast!
[1:57] Kathryn gives an overview of her background in the Life Sciences space.
[4:10] What is the intent of the LIR process? And what are the key elements that must be included as part of a robust process?
[8:13] What are some common issues or barriers related to the LIR process that are often scrutinized by regulatory agencies?
[14:27] Kathryn recommends some best practices for companies that are new to implementing this process as part of their QMS infrastructure as well as those who are focused on improving their existing process.
[19:22] What steps should be taken when the root cause of an issue cannot be pinpointed through the LIR process?
[23:50] Mandy recaps the key learnings from today's podcast and thanks Kathryn for her time!
Mentioned in this Episode:
Kathryn Landes' LinkedIn
Welcome to the 26th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's show is focusing on a topic that has yet to be discussed on the show thus far, and that is the medical device industry and current hot trends from a regulatory perspective! Automating Quality has taken a look at regulatory trends from a broader perspective, but this is the first time they will be diving deep into the current happenings in the device space.
This episode will shed light on some key areas in FDA shift and focus; provide information on innovating trends that are transforming this niche; as well as changes to medical device regulations, setting new precedents that the industry is being held accountable for adopting.
Key Takeaways:
[:29] About today's episode!
[1:20] Mandy explains how the FDA is using science to help innovate and accelerate the medical device industry, as well as why the FDA is so invested in pioneering enhancements to this specialized area of the life sciences industry.
[3:30] The context of use on MDDT tools.
[4:30] The types of categories that fall under the MDDT Program and how these categories are assessed.
[7:55] Have new regulations been implemented that impact the medical device manufacturers?
[10:52] Mandy explains some of the key impacts of these new regulations.
[15:02] Mandy thanks listeners for tuning in!
[16:10] If you have any questions or suggestions for future episodes, you can contact Mandy at [email protected].
Mentioned in this Episode:
FDA MDDT Program
Welcome to the 25th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode is all about leveraging a risk-based approach to develop, implement, and maintain your IT programs, extending to GxP controls and critical infrastructure. Guest industry expert, Phil Becker, will be joining Mandy today to discuss this topic and to provide guidance!
Phil has over 30 years of experience in the IT field. He's an industry thought leader who's held various strategic leadership roles, including Vice President of IT at Acculogix and Fisher Clinical Services, where he was Chief Architect and Developer of the first truly integrated 21 CFR part 11 compliant electronic batch record in the pharmaceutical supply industry. Phil has also developed the industry's first web-based reporting software integrated solution. His vast experience in the space includes software application development, architecture, design for manufacturing, and regulatory compliance.
With Phil's extensive background in the IT space and pharmaceutical arena, he will be providing some incredible guidance on what listeners should consider in terms of IT controls, which risk management tools and approaches you should be taking a look at, and other tactical considerations that will help with the developments and enhancements of your IT program and critical process controls.
Key Takeaways:
[:35] About today's episode.
[1:50] Mandy welcomes Phil to the podcast!
[2:49] How can a risk-based approach be leveraged to develop and implement an IT control strategy to support GxP business systems?
[7:52] What are some risk management tools and approaches that are effective to assess the types of critical controls and the level of robustness that's appropriate for business systems?
[17:47] In regards to business continuity, what are some of the key inputs that should be considered for implementing and maintaining the business continuity program? And how can the effectiveness of these programs typically be assessed?
[28:14] Mandy thanks Phil for joining her this episode!
[30:30] Mandy thanks you all for tuning in for this week's episode. If you want to get in touch with her, you can contact her at [email protected].
Mentioned in this Episode:
Welcome to the 24th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today's episode is focusing on quality risk management — the process for systematically identifying, assessing, and controlling risk to the quality of pharmaceutical products across the product lifecycle. Although the Automating Quality Podcast talks about risk quite often, this episode will be specifically zoning in on the concept of quality risk management (or QRM), how it is implemented, the four key phases that define the QRM lifecycle, and many other important additional elements. Mandy Gervasio will be breaking down this topic in today's solo's episode, highlighting the most foundational key elements of QRM!
Listeners that are new to the industry and veterans alike will get plenty of value from today's episode. So be sure to tune in to brush up on the fundamentals of leveraging a QRM methodology!
Key Takeaways:
[:30] About today's episode.
[1:35] What is QRM? And where is this methodology most often leveraged?
[4:23] How is QRM implemented? And what are some key benefits?
[5:26] How ICH Q9 has impacted the pharma industry, as well as transformed past precedences.
[10:40] Mandy outlines the four key phases that define the QRM lifecycle.
[14:31] Mandy highlights an important element to the QRM lifecycle: risk communication.
[16:02] How ICH Q9 has been the catalyst for a significant paradigm shift in traditional GMP processes and benchmark standards.
[20:05] Mandy wraps up the episode by summarizing what QRM is.
[20:43] What to look forward to in future episodes!
[21:09] Mandy thanks you all for tuning in for this week's episode. If you want to get in touch with her, you can contact her at [email protected].
Mentioned in this Episode:
Quality Risk Management (QRM)
Quality by Design (QBD)
ICH Q9
Welcome to the 23rd episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
Today, Mandy is joined by her co-host, Philippe Gaudreau, and return guest from episodes two and ten, Jay Turner! Jay is the CEO and founder of EduJay LLC., and he is a self-proclaimed learning and development ninja! He has devoted his career to improving people, processes, and programs to produce business results. This includes everything from implementing learning management systems, to designing staff development and leadership development programs, to providing executive coaching.
In this episode, Mandy and Jay are discussing innovation to retrovation — an interesting concept about maintaining GTP (AKA Good Training Practices) in a GxP world. Jay gives his expert feedback on the concepts of GTP, explains what he means by "retrovate" and how it applies to training, gives his top three favorite GTPs and how they can be leveraged in the quality space, and also explains how we can effectively innovate in training when we know it's needed. The feedback that Jay provides in this episode will be incredibly beneficial for listeners who are considering enhancements to their current training and professional development programs. So tune in to get all of his valuable insight on today's topic!
Key Takeaways:
[:32] About today's episode with return guest, Jay Turner!
[2:37] Mandy welcomes Jay back to the show!
[2:49] What does Jay mean by "retrovate" and how does it apply to training?
[7:12] Jay lists his top two out of three GTPs and how they can be leveraged in the quality space.
[14:20] Jay speaks about moving beyond required training and empowering staff members to become a part of the learning function in the organization.
[17:50] Jay explains his third favorite GTP.
[21:26] How can we effectively innovate in training when we know it's needed?
[28:07] Mandy thanks Jay for joining her this episode!
[29:05] Jay gives a quick background about himself and his organization, EduJay.
[31:24] Mandy wraps us this week's episode by thanking listeners for tuning and giving a quick summary of today's episode!
Mentioned in this Episode:
EduJay LLC
Jay Turner's Twitter
Jay Turner's Facebook
Jay Turner's Linkedin
Automating Quality Ep. 10: "Social and Collaborative Learning with Jay Turner"
Automating Quality Ep. 02: "Optimizing Compliance When Implementing an Automated Training Solution with Jay Turner"
Retrovate or Retrovation
GTP
Google VR
Oculus Rift
Design Thinking
Welcome to the 22nd episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
This week, Mandy is joined by her co-host, Philippe Gaudreau, the CEO of Solabs, as well as their guest, Justin Lacombe. Justin has a depth of experience in pharmaceutical development and implementing methodologies founded in Quality by Design (QbD). He is a Chemical Engineer and got his PhD in Chemical Engineering from Rutgers University. He has been spending the past 12 years in the inhalation part of life sciences and pharmaceutical development. He has gotten involved in the area of QbD in the last 4-5 years to try and understand how they can better their development on their products at Experic, where he serves as Director of Pharmaceutical Development and Manufacturing Services.
Today they are going to be discussing Quality by Design — a really important and hot topic in pharmaceuticals! In the past decade, there has been rapid adoption of QbD on the pharmaceutical side of the life sciences industry. So tune in to learn all about what QbD is, what the overall process looks like, the phases and approach of a formalized QbD process from a pharmaceutical development perspective, the relationship between QbD and experimental design, how QbD can help design an effective product development plan, and much more.
Key Takeaways:
[:14] About today's episode.
[1:49] About today's featured guest, Justin Lacombe.
[2:08] Justin introduces himself and gives some background about his career.
[4:05] Justin explains what QbD is and what the overall process looks like. He then goes a bit deeper, explaining the phases and approach of a formalized QbD process from a pharmaceutical development perspective.
[9:01] Justin explains the relationship between QbD and experimental design, and how this all ties into controlled strategy for manufacturing.
[15:18] Justin outlines how critical quality attributes and QbD can help design an effective product development plan.
[20:41] Why is QbD so critical for tech transfer?
[23:23] Mandy highlights the benefits of QbD.
[25:35] Thanks for listening to this week's episode! If you have any questions for Mandy you can contact her at . If you have any questions for this week's guest, Justin Lacombe, you can contact him on his LinkedIn page, linked below.
Mentioned in this Episode:
Justin Lacombe (LinkedIn)
Quality by Design (QbD)
Tech Transfer
Welcome to the 21st episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
This week, Mandy is joined by her co-host, Philippe Gaudreau, the CEO of Solabs, as well as their guest, Michael de la Torre. Michael is Chief Executive Officer of Govzilla — the leading platform for GxP inspection analytics. As a company, they are leveraging the power of Big Data and Machine Learning to make government data accessible, usable, and valuable to everyone who needs it.
As the life sciences industry continues to evolve, with regulatory compliance remaining a critical factor for success, inspection trends are a tool to help companies to develop and enhance their quality management systems. Additionally, being aware of these current trends is a key factor for developing a robust audit readiness program. If you or your industry colleagues are seeking a good tool to enhance your understanding of inspection trends, you do not want to miss this week's episode!
Key Takeaways:
[:29] About today's episode.
[1:20] Michael introduces himself, his expertise background, and his company, Govzilla.
[3:29] Michael speaks about the most important recent FDA inspection and enforcement trends.
[7:49] What are the top items cited by the FDA in human drugs? And have there been any changes in the last couple of years?
[12:22] Michael speaks about changes in the inspection scope since the issuance of the data integrity guidance in 2018.
[16:11] Michael's take on Cloud-based solutions for the life sciences industry.
[18:15] What impact has the FDA had on the market with their efforts on being more open and transparent with their inspections and enforcement data?
[22:53] How Govzilla could be incredibly useful for your organization!
[23:18] Mandy and Philippe thank Michael for joining them this episode.
[25:02] How to get in touch with Michael de la Torre and Mandy Gervasio.
Mentioned in this Episode:
Govzilla
Michael de la Torre on LinkedIn
Welcome to the 20th episode of Automating Quality. Mandy Gervasio is your host, and she's on a mission to bring you hot industry topics with her fellow life sciences partners and friends!
This week, Mandy is wrapping up the six-part series focused around quality culture, the virtual pharma environment, and supply chain management; with Lisa Helmonds, the Vice President of MWA Consulting. She is also joined by her co-host, Philippe Gaudreau, the CEO of Solabs.
In this week's episode, they discuss investigation deviations and non-conformances. Lisa provides many excellent tips to keep in mind as you become familiar with the investigation and deviation management process. These tips will surely help listeners enhance their quality programs! This is a wealth of information for those new to the industry and veterans alike!
This episode officially wraps up the six-part series with Lisa Helmonds! Be sure to subscribe to the podcast for more great episodes on quality management.
Key Takeaways:
[:22] About today's episode.
[1:22] Lisa Helmonds introduces herself and provides some background on her career.
[2:40] About today's topic: investigation deviations and non-conformances.
[3:21] Why are investigations of deviations and non-conformances so important in the industry?
[4:52] Are these investigations required by regulatory agencies or voluntary?
[5:57] Is there a difference between a deviation and a non-conformance?
[9:50] What is a root cause analysis?
[10:12] Tools that can be used in the investigation and the root cause analysis process.
[12:23] What do you do after the root cause is identified?
[18:17] What a full investigation report entails.
[22:46] What constitutes a well-written investigation report.
[27:00] From an audit perspective, what do investigators looks for during inspection regarding deviations?
[29:08] Mandy recommends further listening.
[30:17] Mandy thanks Lisa for joining her for this six-part series.
[31:41] Mandy recaps what the six-part series covered.
[33:08] About next week's episode.
[33:14] If you have any questions, requests, or suggestions, you can contact Mandy Gervasio at [email protected]. If you have any questions for Lisa Helmonds, you can contact her on LinkedIn.
Mentioned in this Episode:
Determine the Root Cause: The Five Whys
Fishbone Diagram for Root Cause Analysis
Failure Mode and Effects Analysis (FMEA)
Design of Experiments
Trend Chart
Part 5: "Management Review and Quality Metrics with Lisa Helmonds from MWA Consulting"
Part 4: "Quality Culture with Lisa Helmonds from MWA Consulting"
Part 3: "Quality Agreements with Lisa Helmonds from MWA Consulting"
Part 2: "Qualifications and Oversight of Contract Service Providers with Lisa Helmonds from MWA Consulting"
Part 1: "Key Elements of Virtual Life Sciences Companies with Lisa Helmonds from MWA Consulting"
MWA Consulting
Lisa Helmonds (LinkedIn)
From the publisher's feed